Oncobiologics Inc Headquartered in Cranbury, NJ, our company is utilizing a proprietary platform to develop a pipeline of next-generation biotherapeutics focused on clinically validated targets in the therapeutic areas of oncology, immuno-oncology, and immunology. We provide world-class, turnkey proof-of-concept services that can take a partner's preclinical candidates from chemistry, manufacture, and control development all the way through Phase II clinical trials.